Malin Corporation | MLC - Market Capitalization


Malin Corporation reported EUR142.92M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 46M 39M Jun/2026
ALKERMES USD 5.88B 1.26B Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Eurofins Scientific SE EUR 11.37B 357.04M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Malin Corporation EUR 142.92M 19.65M Feb/2026
Moderna USD 20.15B 8.53B Mar/2026
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Revvity USD 9.94B 1.03B Mar/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 15.73B 1.39B Mar/2026